Waldenstrom Macroglobulinemia News and Research

RSS
Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics first quarter GAAP net loss increases to $14.5M

LLS increases maximum benefit for myeloma patients to $10,000

LLS increases maximum benefit for myeloma patients to $10,000

Symptomless blood disorder MGUS not a precursor of serious diseases

Symptomless blood disorder MGUS not a precursor of serious diseases